Waters Co. (NYSE:WAT) Shares Bought by State of Alaska Department of Revenue

State of Alaska Department of Revenue raised its holdings in Waters Co. (NYSE:WAT) by 5.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,065 shares of the medical instruments supplier’s stock after buying an additional 777 shares during the period. State of Alaska Department of Revenue’s holdings in Waters were worth $3,026,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of WAT. Davy Asset Management Ltd purchased a new position in shares of Waters during the second quarter worth about $236,000. Livforsakringsbolaget Skandia Omsesidigt grew its holdings in shares of Waters by 46.1% during the second quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 951 shares of the medical instruments supplier’s stock worth $205,000 after buying an additional 300 shares during the last quarter. Hamilton Point Investment Advisors LLC grew its holdings in shares of Waters by 1.7% during the second quarter. Hamilton Point Investment Advisors LLC now owns 25,796 shares of the medical instruments supplier’s stock worth $5,552,000 after buying an additional 442 shares during the last quarter. MainStreet Investment Advisors LLC purchased a new position in shares of Waters during the second quarter worth about $959,000. Finally, Mengis Capital Management Inc. purchased a new position in shares of Waters during the second quarter worth about $2,905,000. Institutional investors own 92.23% of the company’s stock.

A number of research firms recently issued reports on WAT. Bank of America lowered Waters from a “neutral” rating to an “underperform” rating in a report on Tuesday, July 16th. ValuEngine lowered Waters from a “buy” rating to a “hold” rating in a report on Thursday. Wolfe Research began coverage on Waters in a report on Thursday, May 30th. They set an “underperform” rating on the stock. Robert W. Baird lowered their price target on Waters from $211.00 to $209.00 and set a “neutral” rating on the stock in a report on Wednesday, April 24th. Finally, Barclays lowered their price target on Waters from $218.00 to $210.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 24th. Five analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company’s stock. Waters has a consensus rating of “Hold” and an average target price of $210.54.

WAT traded down $2.24 during trading on Friday, reaching $209.52. The company’s stock had a trading volume of 471,952 shares, compared to its average volume of 577,282. Waters Co. has a 52-week low of $167.93 and a 52-week high of $255.21. The firm has a fifty day moving average of $214.46. The company has a market capitalization of $14.63 billion, a P/E ratio of 25.27, a price-to-earnings-growth ratio of 2.36 and a beta of 1.07. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.35 and a quick ratio of 2.89.

Waters (NYSE:WAT) last announced its quarterly earnings data on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.11 by $0.03. Waters had a return on equity of 50.64% and a net margin of 24.09%. The company had revenue of $599.20 million for the quarter, compared to analyst estimates of $601.46 million. During the same quarter in the previous year, the company earned $1.95 EPS. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. As a group, research analysts anticipate that Waters Co. will post 9.02 EPS for the current year.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: How to calculate the annual rate of depreciation

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.